University of Pittsburgh Cancer Institute (UPCI)
Guidelines for the Continuation Process with UPCI after PRC Approval
- Submit a yearly progress report to the DSMC via email to Brandon Kaukus, BS, DSMC Coordinator, at email@example.com for review and approval prior to submitting to the IRB. The Progress Report form can be downloaded here.
- IRB approval, renewal, modifications, and open to accrual should be sent to the UPCI Regulatory Inbox at firstname.lastname@example.org, for inputting to the UPCI Clinical Trials Management Application (CTMA) database.
- In order to maintain updated information such as registration, case report forms, etc. in the CTMA, please review the listed information in the “Data Submission Guidelines” section.